search icon
search icon
Flag Arrow Down
Română
Română
Magyar
Magyar
English
English
Français
Français
Deutsch
Deutsch
Italiano
Italiano
Español
Español
Русский
Русский
日本語
日本語
中国人
中国人

Change Language

arrow down
  • Română
    Română
  • Magyar
    Magyar
  • English
    English
  • Français
    Français
  • Deutsch
    Deutsch
  • Italiano
    Italiano
  • Español
    Español
  • Русский
    Русский
  • 日本語
    日本語
  • 中国人
    中国人
Sections
  • News
  • Exclusive
  • INSCOP Surveys
  • Podcast
  • EU
  • Diaspora
  • Republic of Moldova
  • Politics
  • Economy
  • Current Affairs
  • International
  • Sport
  • Health
  • Education
  • IT&C knowledge
  • Arts & Lifestyle
  • Opinions
  • Elections 2025
  • Environment
About Us
Contact
Privacy policy
Terms and conditions
Quickly scroll through news digests and see how they are covered in different publications!
  • News
  • Exclusive
    • INSCOP Surveys
    • Podcast
    • EU
    • Diaspora
    • Republic of Moldova
    • Politics
    • Economy
    • Current Affairs
    • International
    • Sport
    • Health
    • Education
    • IT&C knowledge
    • Arts & Lifestyle
    • Opinions
    • Elections 2025
    • Environment
133 new news items in the last 24 hours
  1. Home
  2. Health

A study shows that Romanian patients wait, on average, 460 days for access to innovative medicines, seriously affecting critical areas such as oncology.

Andreea Lificiu
whatsapp
facebook
linkedin
x
copy-link copy-link
17 June 2025, 15:32
main event image
Health
https://www.pexels.com/
google-preference

Always see our news on Google

An analysis carried out by Novartis Romania highlights the long delays in Romanian patients' access to innovative medicines, with an average of 460 days from the approval of compensation by the ANMDM. Oncology is the most affected, with 40% of the indications analyzed. Although the assessment process has improved, the compensation steps remain lengthy. The study emphasizes the need for reforms in the reimbursement system to ensure rapid and equitable access to treatment.

Sources

sursa imagine
News.ro
Studiu: Pacienţii români aşteaptă, în medie, 460 de zile ca să primească medicamentele inovatoare compensate/ Aproximativ 40% din totalul indicaţiilor terapeutice analizate au fost de natură oncologică
sursa imagine
G4Media
Studiu: Pacienţii români aşteaptă, în medie, 460 de zile ca să primească medicamentele inovatoare compensate / Aproximativ 40% din totalul indicaţiilor terapeutice analizate au fost de natură oncologică
sursa imagine
G4Media
Studiu: Pacienţii români aşteaptă, în medie, 460 de zile ca să primească medicamentele inovatoare compensate / Aproximativ 40% din totalul indicaţiilor terapeutice analizate au fost de natură oncologică

Latest News

23:05

The only anti-war party in Russia has been excluded from the electoral race.

23:00

Over 1,200 Palestinians have been killed in Gaza since the ceasefire with Israel came into effect in October 2025. UN experts warn of the ongoing genocide.

22:55

The Alba Iulia Court of Appeal rejected the proposal for the preventive arrest of prosecutor Radu George Bucurică, accused of crimes related to the illegal possession and use of a lethal firearm.

22:53

Diana Buzoianu announced that the estimates for the operation of Unit 2 at Cernavodă have been revised negatively: "We are in a much gloomier forecast than we were yesterday."

22:47

Ionel Bogdan (PNL) accuses disinformation on TikTok for the attack on an ambulance and requests the hearing of the president of ANCOM in Parliament.

See more news

NEWS ON THE SAME TOPICS

event image
IT&C knowledge
STADA Report 2026: 56% of Europeans are satisfied with health systems, while 67% indicate staff shortages as a major challenge / 55% use AI for health, but prefer human decisions
event image
Current Affairs
The European Commission has decided to refer Romania to the CJEU due to systemic delays in CNAS payments to pharmacies.
event image
Health
A CES Bucharest study shows that 70% of Romanians self-treat their ailments without medical consultation. 60% do not understand the diagnosis received.
event image
Health
France will start partial reimbursement of treatments for obesity from June, thus becoming the first state in the EU to subsidize these medications.
event image
Current Affairs
Oncological patients' caregivers could receive leave and compensation during medical investigations, according to a USR draft law.
event image
Current Affairs
CNAS proposes new rules for treatments offered in private clinics from public funds
app preview
Personalized news feed, AI-powered search, and notifications in a more interactive experience.
app preview app preview
oncology delays medically compensated medicines

Editor’s Recommendations

main event image
Current Affairs
2 hours ago

ANAR: The level of the Danube at Cernavodă is decreasing more sharply than expected.

Sources
imagine sursa
imagine sursa
imagine sursa
main event image
Current Affairs
1 hour ago

Diana Buzoianu announced that the estimates for the operation of Unit 2 at Cernavodă have been revised negatively: "We are in a much gloomier forecast than we were yesterday."

Sources
imagine sursa
imagine sursa
main event image
Current Affairs
9 hours ago

SPECIAL Informat.ro / From "Black Volga" to TikTok. How an urban legend became a real risk in Romania

main event image
IT&C knowledge
10 hours ago

DOC/ The jellyfish that refuses to age and its lessons for regenerative medicine

app preview
Personalized news feed, AI-powered search, and notifications in a more interactive experience.
app preview
app store badge google play badge
  • News
  • Exclusive
  • INSCOP Surveys
  • Podcast
  • EU
  • Diaspora
  • Republic of Moldova
  • Politics
  • Economy
  • Current Affairs
  • International
  • Sport
  • Health
  • Education
  • IT&C knowledge
  • Arts & Lifestyle
  • Opinions
  • Elections 2025
  • Environment
  • About Us
  • Contact
Privacy policy
Cookies Policy
Terms and conditions
Open source licenses
All rights reserved Strategic Media Team SRL

Technology in partnership with

anpc-sal anpc-sol